BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15824370)

  • 1. Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia.
    Antozzi C; Frassoni C; Vincent A; Regondi MC; Andreetta F; Bernasconi P; Ciano C; Chang T; Cornelio F; Spreafico R; Mantegazza R
    Neurology; 2005 Apr; 64(7):1290-3. PubMed ID: 15824370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymoma-associated neuromyotonia with antibodies against voltage-gated potassium channels presenting as chronic intestinal pseudo-obstruction.
    Viallard JF; Vincent A; Moreau JF; Parrens M; Pellegrin JL; Ellie E
    Eur Neurol; 2005; 53(2):60-3. PubMed ID: 15753614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations.
    Kleopa KA; Elman LB; Lang B; Vincent A; Scherer SS
    Brain; 2006 Jun; 129(Pt 6):1570-84. PubMed ID: 16613892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune-mediated neuromyotonia (Isaacs' syndrome)--clinical aspects and pathomechanism].
    Arimura K; Watanabe O
    Brain Nerve; 2010 Apr; 62(4):401-10. PubMed ID: 20420181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifocal paraneoplastic cortical encephalitis associated with myasthenia gravis and thymoma.
    Hammoud K; Kandimala G; Warnack W; Vernino S
    Arch Neurol; 2009 Nov; 66(11):1407-9. PubMed ID: 19901174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical spectrum of voltage-gated potassium channel autoimmunity.
    Tan KM; Lennon VA; Klein CJ; Boeve BF; Pittock SJ
    Neurology; 2008 May; 70(20):1883-90. PubMed ID: 18474843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired generalised neuromyotonia, cutaneous lupus erythematosus and alopecia areata in a patient with myasthenia gravis.
    O'Sullivan SS; Mullins GM; Neligan A; McNamara B; Galvin RJ
    Clin Neurol Neurosurg; 2007 May; 109(4):374-5. PubMed ID: 17239529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies.
    Oh SJ; Alapati A; Claussen GC; Vernino S
    Muscle Nerve; 2003 Jun; 27(6):757-60. PubMed ID: 12766989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
    Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
    Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum antibodies in epilepsy and seizure-associated disorders.
    McKnight K; Jiang Y; Hart Y; Cavey A; Wroe S; Blank M; Shoenfeld Y; Vincent A; Palace J; Lang B
    Neurology; 2005 Dec; 65(11):1730-6. PubMed ID: 16344514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM-containing fraction suppressed voltage-gated potassium channels in acquired neuromyotonia.
    Kurono A; Arimura K; Watanabe O; Tomimitsu H; Nagado T; Sonoda Y; Kameyama M; Osame M
    Acta Neurol Scand; 2006 Mar; 113(3):185-8. PubMed ID: 16441249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia.
    Tomimitsu H; Arimura K; Nagado T; Watanabe O; Otsuka R; Kurono A; Sonoda Y; Osame M; Kameyama M
    Ann Neurol; 2004 Sep; 56(3):440-4. PubMed ID: 15349875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isaacs' syndrome (autoimmune neuromyotonia) in a patient with systemic lupus erythematosus.
    Taylor PW
    J Rheumatol; 2005 Apr; 32(4):757-8. PubMed ID: 15801039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Isaacs' syndrome following complete recovery of voltage-gated potassium channel antibody-associated limbic encephalitis.
    Takahashi H; Mori M; Sekiguchi Y; Misawa S; Sawai S; Hattori T; Kuwabara S
    J Neurol Sci; 2008 Dec; 275(1-2):185-7. PubMed ID: 18801496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voltage-gated potassium channel antibodies associated limbic encephalitis in a patient with invasive thymoma.
    Ohshita T; Kawakami H; Maruyama H; Kohriyama T; Arimura K; Matsumoto M
    J Neurol Sci; 2006 Dec; 250(1-2):167-9. PubMed ID: 17028029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired neuromyotonia in childhood: case report and review.
    Gonzalez G; Barros G; Russi ME; Nuñez A; Scavone C
    Pediatr Neurol; 2008 Jan; 38(1):61-3. PubMed ID: 18054698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibodies directed to voltage-gated potassium channels in sera from acquired neuromyotonia and related disorders].
    Arimura K
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1235-6. PubMed ID: 10791086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability.
    Vernino S; Lennon VA
    Muscle Nerve; 2002 Nov; 26(5):702-7. PubMed ID: 12402293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent topics on paraneoplastic neurological syndromes: anti-VGKC antibodies].
    Watanabe O; Arimura K
    Nihon Naika Gakkai Zasshi; 2008 Aug; 97(8):1838-43. PubMed ID: 18833704
    [No Abstract]   [Full Text] [Related]  

  • 20. Isaacs' syndrome as the initial presentation of malignant thymoma and associated with double-positive voltage-gated potassium channel complex antibodies, a case report.
    Li KC; Liao MF; Wu YR; Lyu RK
    BMC Neurol; 2022 Mar; 22(1):74. PubMed ID: 35246046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.